Oligodendroglioma: all 225 studies

Page 1 of 3. Open to participants first (31), then studies with results posted, then the rest; newest registration first within each.

• Safusidenib for Patients With Newly Diagnosed IDH1-mutant CNS WHO Grade 3 Oligodendroglioma and Astrocytoma - a Single Arm Phase II StudyNot yet recruitingNCT07832123Phase 2
• Phase II Elderly/Frail Pts With Newly Diagnosed or Recurrent Malignant Glioma Treated With Cesium-131 GammaTile®Not yet recruitingNCT07821112Phase 2
• Safety and Efficacy Study of Safusidenib in Participants With Grade 2 IDH1-Mutant GliomaNot yet recruitingNCT07712757Phase 3
• Safety and Efficacy Study of Safusidenib in Participants With IDH1-Mutant Glioma Who Discontinued Vorasidenib Treatment Due to Progressive DiseaseRecruitingNCT07703436Phase 2
• Living Well With Brain Cancer: A Group-Based Intervention to Promote Whole-Person Well-BeingNot yet recruitingNCT07628647Not applicable
• Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade GliomasRecruitingNCT07468136Phase 1/2
• Inflammation in Primary and Secondary Malignancies of the Central Nervous System Using [C-11]-CS1P1RecruitingNCT07462507Phase 2
• Pre-Radiation Chemotherapy for Newly Diagnosed High-Grade Glioma.RecruitingNCT07439172Phase 2
• Amino Acid PET-based Response Assessment in IDH-mutant Gliomas (APPEAR)RecruitingNCT07159607
• FearLess in NeuroOncologyRecruitingNCT06989086Not applicable
• HOBSCOTCH-CA (HOme-Based Self-management and COgnitive Training CHanges Lives in Brain CAncer)RecruitingNCT06930846Not applicable
• ADAGiO: Adoptive Cellular Therapy for the TreAtment of Recurrent OliGodendrogliOma (OG) Adult PatientsRecruitingNCT06254326Phase 1
• Ga-68 Prostate Specific Membrane Antigen PET/CT in GliomasNot yet recruitingNCT06241391Not applicable
• Study of Olutasidenib and Temozolomide in HGGRecruitingNCT06161974Phase 2
• Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of AgeRecruitingNCT05956821Phase 1/2
• A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent GliomaRecruitingNCT05698524Phase 1
• Hierarchical Diagnosis for Adult Diffuse Glioma Based on Deep LearningRecruitingNCT05624736
• Correlation Between Psychological Stress and Progression of Newly Oligodendroglioma Towards Secondary GliomaNot yet recruitingNCT05536986
• Sintilimab (One Anti-PD-1 Antibody) Plus Low-dose Bevacizumab for ctDNAlevel- Relapse and Clinical-relapse OligodendrogliomaRecruitingNCT05512351Phase 2
• All-Trans Retinoic Acid (ATRA) Plus PD-1 Inhibition in Recurrent IDH-Mutant GliomaRecruitingNCT05345002Phase 2
• A Clinical Study to Improve Brain Function and Quality of Life of Patients With Newly Diagnosed Brain Tumors (Gliomas).RecruitingNCT05331521Phase 3
• SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)RecruitingNCT05303519Phase 3
• PRO-GLIO: PROton Versus Photon Therapy in IDH-mutated Diffuse Grade II and III GLIOmasRecruitingNCT05190172Not applicable
• SJ901: Evaluation of Mirdametinib in Children, Adolescents, and Young Adults With Low-Grade GliomaRecruitingNCT04923126Phase 1/2
• A Randomized Trial of Delayed Radiotherapy in Patients Low-grade Oligodendrogliomas Requiring a Treatment Other Than SurgeryRecruitingNCT04702581Phase 3
• Proton Therapy Research Infrastructure- ProTRAIT- Neuro-oncologyRecruitingNCT04648462
• Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) GlioblastomasRecruitingNCT04623931Phase 2
• Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System NeoplasmsRecruitingNCT04541082Phase 1
• Implantable Microdevice In Primary Brain TumorsRecruitingNCT04135807Early Phase 1
• HSV G207 in Children With Recurrent or Refractory Cerebellar Brain TumorsRecruitingNCT03911388Phase 1
• Efficacy of Post-radiation Adjuvant Temozolomide Chemotherapy in Residue Low-grade GliomaRecruitingNCT01649830Phase 3
• PARP Inhibition for Gliomas (PI-4G or π4g)TerminatedNCT05297864Phase 2Results posted
• Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Glioblastoma or Other Primary Central Nervous System Tumors Harboring Activating FGFR1-3 AlterationsTerminatedNCT05267106Phase 2Results posted
• INCB7839 in Treating Children With Recurrent/Progressive High-Grade GliomasCompletedNCT04295759Phase 1Results posted
• Abemaciclib in Patients With OligodendrogliomaCompletedNCT03969706Phase 2Results posted
• Neural Stem Cell Based Virotherapy of Newly Diagnosed Malignant GliomaCompletedNCT03072134Phase 1Results posted
• Phase 1b Study PVSRIPO for Recurrent Malignant Glioma in ChildrenCompletedNCT03043391Phase 1Results posted
• Protein Phosphatase 2A Inhibitor, in Recurrent GlioblastomaCompletedNCT03027388Phase 2Results posted
• A Study of Varlilumab and IMA950 Vaccine Plus Poly-ICLC in Patients With WHO Grade II Low-Grade Glioma (LGG)TerminatedNCT02924038Phase 1Results posted
• First in Patient Study for PF-06840003 in Malignant GliomasTerminatedNCT02764151Phase 1Results posted
• Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Pediatric Patients With BRAF V600 Mutation Positive LGG or Relapsed or Refractory HGG TumorsCompletedNCT02684058Phase 2Results posted
• Safety and Efficacy of PD0332991 (Palbociclib), a Cyclin-dependent Kinase 4 and 6 Inhibitor, in Patients With Oligodendroglioma or Recurrent Oligoastrocytoma Anaplastic With the Activity of the Protein RB PreservedCompletedNCT02530320Phase 2Results posted
• Using MRI-Guided Laser Heat Ablation to Induce Disruption of the Peritumoral Blood Brain Barrier to Enhance Delivery and Efficacy of Treatment of Pediatric Brain TumorsTerminatedNCT02372409Phase 2Results posted
• Palbociclib Isethionate in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System TumorsTerminatedNCT02255461Phase 1Results posted
• Carboxylesterase-Expressing Allogeneic Neural Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade GliomasActive, not recruitingNCT02192359Phase 1Results posted
• Alisertib and Fractionated Stereotactic Radiosurgery in Treating Patients With Recurrent High Grade GliomasCompletedNCT02186509Phase 1Results posted
• 18F-FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients With Newly-Diagnosed or Recurrent GliomasTerminatedNCT02175745Not applicableResults posted
• Temozolomide and Ascorbic Acid in Treating Patients With Recurrent High-Grade GliomaTerminatedNCT02168270Phase 1Results posted
• Everolimus With and Without Temozolomide in Adult Low Grade GliomaTerminatedNCT02023905Phase 2Results posted
• Genetically Modified Neural Stem Cells, Flucytosine, and Leucovorin for Treating Patients With Recurrent High-Grade GliomasCompletedNCT02015819Phase 1Results posted
• Intraarterial Infusion Of Erbitux and Bevacizumab For Relapsed/Refractory Intracranial Glioma In Patients Under 22TerminatedNCT01884740Phase 1/2Results posted
• Imetelstat Sodium in Treating Younger Patients With Recurrent or Refractory Brain TumorsTerminatedNCT01836549Phase 2Results posted
• Phase I/II Trial of AXL1717 in the Treatment of Recurrent Malignant AstrocytomasTerminatedNCT01721577Phase 1/2Results posted
• Phase II NKTR-102 In Bevacizumab-Resistant High Grade GliomaCompletedNCT01663012Phase 2Results posted
• Bevacizumab With or Without Anti-Endoglin Monoclonal Antibody TRC105 in Treating Patients With Recurrent Glioblastoma MultiformeCompletedNCT01648348Phase 1/2Results posted
• Vaccine for Patients With Newly Diagnosed or Recurrent Low-Grade GliomaCompletedNCT01635283Phase 2Results posted
• Bevacizumab With or Without Trebananib in Treating Patients With Recurrent Brain TumorsCompletedNCT01609790Phase 2Results posted
• Efficacy of Hypofractionated XRT w/Bev. + Temozolomide for Recurrent GliomasTerminatedNCT01478321Phase 2Results posted
• Sunitinib Malate in Treating Younger Patients With Recurrent, Refractory, or Progressive Malignant Glioma or EpendymomaCompletedNCT01462695Phase 2Results posted
• BIBF 1120 for Recurrent High-Grade GliomasCompletedNCT01380782Phase 2Results posted
• RO4929097and Bevacizumab in Treating Patients With Progressive or Recurrent Malignant GliomaTerminatedNCT01189240Phase 1/2Results posted
• Ritonavir and Lopinavir in Treating Patients With Progressive or Recurrent High-Grade GliomaTerminatedNCT01095094Phase 2Results posted
• Temsirolimus and Perifosine in Treating Patients With Recurrent or Progressive Malignant GliomaCompletedNCT01051557Phase 1/2Results posted
• A Randomized Phase II Trial of Vandetanib (ZD6474) in Combination With Carboplatin Versus Carboplatin Alone Followed by Vandetanib Alone in Adults With Recurrent High-Grade GliomasCompletedNCT00995007Phase 2Results posted
• Dasatinib and Bevacizumab in Treating Patients With Recurrent or Progressive High-Grade Glioma or Glioblastoma MultiformeCompletedNCT00892177Phase 2Results posted
• Bendamustine Hydrochloride in Treating Patients With Recurrent or Progressive Anaplastic GliomaCompletedNCT00823797Phase 2Results posted
• Everolimus in Treating Patients With Recurrent Low-Grade GliomaCompletedNCT00823459Phase 2Results posted
• Cilengitide in Treating Younger Patients With Recurrent or Progressive High-Grade Glioma That Has Not Responded to Standard TherapyCompletedNCT00679354Phase 2Results posted
• Tandutinib Plus Bevacizumab to Treat Recurrent Brain TumorsCompletedNCT00667394Phase 2Results posted
• Intensive Chemotherapy and Autotransplantation for Patients With Newly Diagnosed Anaplastic OligodendrogliomaCompletedNCT00588523Phase 2Results posted
• Efficacy of Protracted Temozolomide in Patients With Progressive High Grade GliomaCompletedNCT00575887Phase 2Results posted
• Sunitinib in Treating Patients With Recurrent Malignant GliomasCompletedNCT00499473Phase 2Results posted
• Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck CancerCompletedNCT00492089Phase 2Results posted
• The Effects of Continuous 28-day (28/28) Temozolomide Chemotherapy in Subjects With Recurrent Malignant Glioma Who Have Failed the Conventional 5-day (5/28) Treatment (P04601)CompletedNCT00392171Phase 2Results posted
• Viral Therapy in Treating Patients With Recurrent Glioblastoma MultiformeCompletedNCT00390299Phase 1Results posted
• Bevacizumab and Irinotecan in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma, Medulloblastoma, Ependymoma, or Low Grade GliomaCompletedNCT00381797Phase 2Results posted
• VEGF Trap in Treating Patients With Recurrent Malignant Gliomas That Did Not Respond to TemozolomideCompletedNCT00369590Phase 2Results posted
• Phase II Study of Irinotecan HCI for Recurrent Anaplastic Astrocytomas, Mixed Malignant Gliomas, and OligodendrogliomasTerminatedNCT00360828Phase 2Results posted
• Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant GliomaCompletedNCT00112736Phase 1/2Results posted
• Lapatinib in Treating Young Patients With Recurrent or Refractory Central Nervous System TumorsCompletedNCT00095940Phase 1/2Results posted
• FR901228 in Treating Patients With Recurrent High-Grade GliomasCompletedNCT00085540Phase 1/2Results posted
• Imatinib Mesylate in Treating Patients With Recurrent Brain TumorCompletedNCT00049127Phase 1/2Results posted
• Erlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive MeningiomaCompletedNCT00045110Phase 1/2Results posted
• Gefitinib and Radiation Therapy in Treating Children With Newly Diagnosed GliomasCompletedNCT00042991Phase 1/2Results posted
• Antineoplaston Therapy in Treating Patients With Recurrent or Refractory OligodendrogliomaTerminatedNCT00003472Phase 2Results posted
• GliomaAI-Oligo: MRI-Based Detection of IDH Mutant OligodendrogliomaCompletedNCT07673705
• Peds CHAMP1ON - Hematopoietic Stem Cell And Monoclonal Antibody PD-1 Blockade for RecurreNt Pediatric High-Grade GliomaActive, not recruitingNCT07031765Phase 1
• Whole-Brain Tumor Burden Metrics with Inflammatory and Molecular Markers to Predict Postoperative Neurocognitive Decline in GliomaCompletedNCT06885333
• Clinical Trial Evaluating Safety of 5-Aminolevulinic Acid (5-ALA) Combined With CV01 Delivery of Ultrasound for Sonodynamic Therapy (SDT) in Patients With Newly Diagnosed High-Grade Glioma (HGG) Prior to Resection and Standard Adjuvant Therapy (ALA SDT GLIOMA 401)CompletedNCT06665724Phase 1
• Comparing Telehealth and In-person Assessments in Glioma Patients Receiving Oral ChemotherapyCompletedNCT06625047Phase 4
• CBT-I in Primary Brain Tumor Patients: Phase IIc Randomized Feasibility Pilot TrialCompletedNCT06439420Phase 2
• Adaptive Radiotherapy and MRIs Based on Patients With Newly Diagnosed High-Grade GliomaActive, not recruitingNCT06108206
• Prospective Evaluation of AI R&D Tool in Adult Glioma and Other Primary Brain Tumours (PEAR-GLIO)TerminatedNCT06038760
• Testing Cerebrospinal Fluid for Cell-free Tumor DNA in Children, Adolescents, and Young Adults With Brain TumorsTerminatedNCT05934630
• Studying the Safety, Efficacy, and Pharmacokinetic Characteristics of BNCT in Patients With Recurrent High-grade GliomasTerminatedNCT05737212Phase 1/2
• Vorasidenib Expanded Access ProgramApproved for marketingNCT05592743
• A Study of AB-218 in Patients With IDH1 Mutated Low Grade GliomaCompletedNCT05577416Early Phase 1
• Study of Safety and Pharmacokinetic Properties of Oral OKN-007 in Patients with Recurrent High-Grade GliomaActive, not recruitingNCT05561374Phase 1
• Investigational Imaging Technique During Brain SurgerySuspendedNCT05513859Not applicable
• Study of Vorasidenib and Pembrolizumab Combination in Recurrent or Progressive IDH-1 Mutant GliomaActive, not recruitingNCT05484622Phase 1

← Oligodendroglioma overview